477 related articles for article (PubMed ID: 19728332)
1. Nationwide survey of single-system single site Langerhans cell histiocytosis in Japan.
Morimoto A; Ishida Y; Suzuki N; Ohga S; Shioda Y; Okimoto Y; Kudo K; Ishii E;
Pediatr Blood Cancer; 2010 Jan; 54(1):98-102. PubMed ID: 19728332
[TBL] [Abstract][Full Text] [Related]
2. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
3. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
[TBL] [Abstract][Full Text] [Related]
4. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study.
Titgemeyer C; Grois N; Minkov M; Flucher-Wolfram B; Gatterer-Menz I; Gadner H
Med Pediatr Oncol; 2001 Aug; 37(2):108-14. PubMed ID: 11496348
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
6. 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society.
Weitzman S; Braier J; Donadieu J; Egeler RM; Grois N; Ladisch S; Pötschger U; Webb D; Whitlock J; Arceci RJ
Pediatr Blood Cancer; 2009 Dec; 53(7):1271-6. PubMed ID: 19731321
[TBL] [Abstract][Full Text] [Related]
7. Predictors of outcome in children with Langerhans cell histiocytosis.
Jubran RF; Marachelian A; Dorey F; Malogolowkin M
Pediatr Blood Cancer; 2005 Jul; 45(1):37-42. PubMed ID: 15768381
[TBL] [Abstract][Full Text] [Related]
8. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
Davidson L; McComb JG; Bowen I; Krieger MD
J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
[TBL] [Abstract][Full Text] [Related]
9. Primary musculoskeletal Langerhans cell histiocytosis in children: an analysis for a 3-decade period.
Arkader A; Glotzbecker M; Hosalkar HS; Dormans JP
J Pediatr Orthop; 2009 Mar; 29(2):201-7. PubMed ID: 19352248
[TBL] [Abstract][Full Text] [Related]
10. Hungarian experience with Langerhans cell histiocytosis in childhood.
Müller J; Garami M; Hauser P; Schuler D; Csóka M; Kovács G; Rényi I; Kovács G; Marosi A; Galántai I; Békési A; Kajtár P; Kiss CS; Nagy K; Bartyik K; Masáth P; Kriván G;
Pediatr Hematol Oncol; 2006 Mar; 23(2):135-42. PubMed ID: 16651242
[TBL] [Abstract][Full Text] [Related]
11. Langerhans' cell histiocytosis of the temporal bone in children.
Saliba I; Sidani K; El Fata F; Arcand P; Quintal MC; Abela A
Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):775-86. PubMed ID: 18355926
[TBL] [Abstract][Full Text] [Related]
12. Langerhans cell histiocytosis in neonates.
Minkov M; Prosch H; Steiner M; Grois N; Pötschger U; Kaatsch P; Janka-Schaub G; Gadner H
Pediatr Blood Cancer; 2005 Nov; 45(6):802-7. PubMed ID: 15770639
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution.
Braier J; Chantada G; Rosso D; Bernaldez P; Amaral D; Latella A; Balancini B; Masautis A; Goldberg J
Pediatr Hematol Oncol; 1999; 16(5):377-85. PubMed ID: 10505313
[TBL] [Abstract][Full Text] [Related]
14. [Experiences with Langerhans' cell histiocytosis in children in Hungary].
Müller J; Koós R; Garami M; Hauser P; Borgulya G; Schuler D; Benyó G; Magyarosy E; Galántai I; Milei K; Török K; Bárdi E; Hunyadi K; Gábor K; Masáth P; Bodnár L; Kovács G
Magy Onkol; 2004; 48(4):289-95. PubMed ID: 15655573
[TBL] [Abstract][Full Text] [Related]
15. Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors.
Lau LM; Stuurman K; Weitzman S
Pediatr Blood Cancer; 2008 Mar; 50(3):607-12. PubMed ID: 17973322
[TBL] [Abstract][Full Text] [Related]
16. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group.
Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM
Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016
[TBL] [Abstract][Full Text] [Related]
17. Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan.
Kudo K; Ohga S; Morimoto A; Ishida Y; Suzuki N; Hasegawa D; Nagatoshi Y; Kato S; Ishii E
Bone Marrow Transplant; 2010 May; 45(5):901-6. PubMed ID: 19767778
[TBL] [Abstract][Full Text] [Related]
18. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
[TBL] [Abstract][Full Text] [Related]
19. Langerhans cell histiocytosis in children less than 2 years of age.
Kusuma Kumary P; Priyakumari T; Chellam VG; James FV; Nair MK
Indian Pediatr; 1999 Jan; 36(1):29-36. PubMed ID: 10709120
[TBL] [Abstract][Full Text] [Related]
20. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
